• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hemojuvelin hemochromatosis receiving iron chelation therapy with deferasirox: improvement of liver disease activity, cardiac and hematological function.

作者信息

Maeda Takashi, Nakamaki Tsuyoshi, Saito Bungo, Nakashima Hidetoshi, Ariizumi Hirotsugu, Yanagisawa Kouji, Hattori Ai, Tatsumi Yasuaki, Hayashi Hisao, Suzuki Kenshi, Tomoyasu Shigeru

出版信息

Eur J Haematol. 2011 Nov;87(5):467-9. doi: 10.1111/j.1600-0609.2011.01693.x. Epub 2011 Oct 2.

DOI:10.1111/j.1600-0609.2011.01693.x
PMID:21848699
Abstract
摘要

相似文献

1
Hemojuvelin hemochromatosis receiving iron chelation therapy with deferasirox: improvement of liver disease activity, cardiac and hematological function.接受地拉罗司铁螯合治疗的血色素沉着症相关铁过载：肝脏疾病活动度、心脏及血液学功能的改善
Eur J Haematol. 2011 Nov;87(5):467-9. doi: 10.1111/j.1600-0609.2011.01693.x. Epub 2011 Oct 2.
2
Iron chelation with deferasirox in two patients with HFE hemochromatosis and chronic anemia.两名 HFE 血色病合并慢性贫血患者使用地拉罗司进行铁螯合治疗。
Acta Haematol. 2011;126(2):119-21. doi: 10.1159/000328039. Epub 2011 Jun 10.
3
Deferasirox reduces iron overload in a murine model of juvenile hemochromatosis.地拉罗司可减轻青少年血色素沉着症小鼠模型中的铁过载。
Exp Biol Med (Maywood). 2009 May;234(5):492-503. doi: 10.3181/0811-RM-337. Epub 2009 Feb 20.
4
Oral iron chelator deferasirox in the treatment of secondary hemochromatosis following bone marrow transplantation in a patient with severe aplastic anemia.口服铁螯合剂地拉罗司治疗重型再生障碍性贫血骨髓移植后继发铁过载
Acta Haematol. 2011;125(4):219-21. doi: 10.1159/000322802. Epub 2011 Jan 25.
5
Deferasirox induced liver injury in haemochromatosis.
J Coll Physicians Surg Pak. 2010 Aug;20(8):551-3.
6
Dose titration of deferasirox iron chelation therapy by magnetic resonance imaging for chronic iron storage disease in three adult red bald-headed uakari (Cacajao calvus rubicundus).通过磁共振成像对三只成年红秃猴（Cacajao calvus rubicundus）的慢性铁储存疾病进行地拉罗司铁螯合疗法的剂量滴定。
J Zoo Wildl Med. 2014 Jun;45(2):339-49. doi: 10.1638/2013-0228R.1.
7
HJV hemochromatosis, iron overload, and hypogonadism in a Brazilian man: treatment with phlebotomy and deferasirox.一名巴西男性的HJV血色素沉着症、铁过载和性腺功能减退：静脉放血和地拉罗司治疗
Acta Haematol. 2010;124(4):204-5. doi: 10.1159/000321493. Epub 2010 Nov 12.
8
Deferasirox (Exjade) for the treatment of iron overload.地拉罗司（恩瑞格）用于治疗铁过载。
Acta Haematol. 2009;122(2-3):165-73. doi: 10.1159/000243801. Epub 2009 Nov 10.
9
Deferasirox in patients with iron overload secondary to hereditary hemochromatosis: results of a 1-yr Phase 2 study.去铁胺治疗遗传性血色素沉着症继发铁过载患者：一项为期1年的2期研究结果
Eur J Haematol. 2015 Dec;95(6):545-50. doi: 10.1111/ejh.12530. Epub 2015 Mar 27.
10
Deferasirox pharmacokinetics evaluation in a woman with hereditary haemochromatosis and heterozygous β-thalassaemia.遗传性血色素沉着症合并杂合β-地中海贫血女性患者地拉罗司药代动力学评价。
Biomed Pharmacother. 2016 Dec;84:1510-1512. doi: 10.1016/j.biopha.2016.11.041. Epub 2016 Nov 20.

引用本文的文献

1
An Iron-chelating Agent Improved the Cardiac Function in a Patient with Severe Heart Failure Due to Hereditary Hemochromatosis.一种铁螯合剂改善了遗传性血色素沉着症所致严重心力衰竭患者的心脏功能。
Intern Med. 2024 Jan 15;63(2):253-258. doi: 10.2169/internalmedicine.1809-23. Epub 2023 May 17.
2
Juvenile Hemochromatosis due to a Homozygous Variant in the Gene.因该基因纯合变异导致的青少年血色素沉着症。
Case Rep Pediatr. 2022 Apr 11;2022:7743748. doi: 10.1155/2022/7743748. eCollection 2022.
3
Genotypic and phenotypic spectra of hemojuvelin mutations in primary hemochromatosis patients: a systematic review.
原发性血色病患者血幼素基因突变的基因型和表型谱：系统评价。
Orphanet J Rare Dis. 2019 Jul 8;14(1):171. doi: 10.1186/s13023-019-1097-2.
4
Reversal of end-stage heart failure in juvenile hemochromatosis with iron chelation therapy: a case report.铁螯合疗法逆转青少年血色素沉着症终末期心力衰竭：一例报告
J Med Case Rep. 2018 Jan 26;12(1):18. doi: 10.1186/s13256-017-1526-6.
5
A late presentation of a fatal disease: juvenile hemochromatosis.一种致命疾病的晚期表现：青少年血色素沉着症。
Case Rep Med. 2013;2013:875093. doi: 10.1155/2013/875093. Epub 2013 Sep 11.